NCT05037240

Quercetin in the Prevention of Covid-19 Infection

Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of an Oral Nutritional Supplement Based on Quercetin in the Prevention of Covid-19 Infection for a Duration of 3 Months

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Azienda di Servizi alla Persona di Pavia · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

Quercetin is a flavonol, a subclass of flavonoid compounds. Of the flavonol molecules, quercetin is the most abundant in fruit and vegetables. Quercetin flavonol is characterized by 3 crucial properties: antioxidant, anti-inflammatory and immunomodulatory. The combination of these 3 properties makes quercetin an excellent candidate for dealing with situations in which oxidative stress, inflammation and the immune system are involved. The purpose of the study is to evaluate the effectiveness of an oral nutritional supplement based on quercetin in the prevention of Covid-19 infection.

Conditions

• Covid19

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Quercetin	Quercetin (500 mg), 2 times a day for 3 months
COMBINATION_PRODUCT	Placebo	500 mg, 2 times a day for 3 months

Timeline

• Start date: 2021-01-12
• Primary completion: 2021-04-06
• Completion: 2021-05-25
• First posted: 2021-09-08
• Last updated: 2021-09-08

Locations

1 site across 1 country: Italy